Iguratimod: novel DMARD promising for rheumatoid arthritis

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1450, 2004-01, pp. : 7-7

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Leflunomide: a novel DMARD for the treatment of rheumatoid arthritis

By Alldred A.   Emery P.  

Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 1, 2001-01 ,pp. : 125-137

Informa Healthcare

Access to resources Recommend Favorite

JAK inhibition for the treatment of rheumatoid arthritis: a new era in oral DMARD therapy

By Vaddi Kris   Luchi Monica  

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 7, 2012-07 ,pp. : 961-973

Informa Healthcare

Access to resources Recommend Favorite

IL-33: a promising therapeutic target for rheumatoid arthritis?

By Yuan Feng-Lai   Li Xia   Lu Wei-Guo   Li Cheng-Wan   Xu Rui-Sheng   Dong Jian  

Expert Opinion on Therapeutic Targets, Vol. 15, Iss. 5, 2011-05 ,pp. : 529-534

Informa Healthcare

Access to resources Recommend Favorite

Biological therapies promising in juvenile rheumatoid arthritis

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 21, Iss. 2, 2005-02 ,pp. : 8-11

Adis International

Access to resources Recommend Favorite

CTLA4-Ig promising in rheumatoid arthritis

By  

Inpharma, Vol. 1, Iss. 1414, 2003-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite